m6A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer

肿瘤科 医学 血液学 内科学 化疗 肺癌 癌症 癌症研究
作者
Zhihui Zhang,Chaoqi Zhang,Zhaoyang Yang,Guochao Zhang,Peng Wu,Yuejun Luo,Qingpeng Zeng,Lide Wang,Qi Xue,Yi Zhang,Nan Sun,Jie He
出处
期刊:Journal of Hematology & Oncology [BioMed Central]
卷期号:14 (1) 被引量:45
标识
DOI:10.1186/s13045-021-01173-4
摘要

Abstract Small-cell lung cancer (SCLC) is a devastating subtype of lung cancer with few therapeutic options. Despite the advent of immunotherapy, platinum-based chemotherapy is still the irreplaceable first-line therapy for SCLCs. However, drug resistance will invariably occur in most patients and the outcomes are heterogeneous. Therefore, clinically feasible classification strategies and potential therapeutic targets for overcoming chemotherapy resistance are urgently needed. N 6 -methyladenosine (m 6 A) is a novel epigenetic decisive factor that is involved in tumor progression and drug resistance. However, almost nothing is known about m 6 A modification in SCLC. Here, we assessed 200 SCLC samples from patients who underwent chemotherapy from three different cohorts, including a validation cohort containing 71 cases with qPCR data and an independent cohort containing 79 cases with immunohistochemistry data (quantified as H-score). We systematically characterized the predictive landscape of m 6 A regulators in SCLC patients following with chemotherapy. Using the LASSO Cox model, we built a seven-regulator-based ( ZCCHC4 , IGF2BP3 , ALKBH5 , YTHDF3 , METTL5 , G3BP1 , and RBMX ) chemotherapy benefit predictive classifier (m 6 A score) and subsequently validated the classifier in two other cohorts. Time-dependent ROC and C-index analyses showed that the m 6 A score to possessed superior predictive power for chemotherapy benefit in comparison with other clinicopathological parameters. A multicohort multivariate analysis revealed that the m 6 A score is an independent factor that affects survival benefit across multiple cohorts. Our in vitro experimental results revealed that three regulators—ZCCHC4, G3BP1, and RBMX—may serve as promising novel therapeutic targets for overcoming chemoresistance in SCLCs. Our results, for the first time, demonstrate the predictive significance of m 6 A regulators for chemotherapy benefit, as well as their potential as therapeutic targets for overcoming chemotherapy resistance in SCLC patients. The m 6 A score was found to be a reliable prognostic tool that may help guide chemotherapy decisions for patients with SCLC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
量子星尘发布了新的文献求助10
1秒前
oblivious完成签到,获得积分10
2秒前
mkb完成签到,获得积分10
2秒前
2秒前
向秋发布了新的文献求助10
3秒前
王云骢完成签到,获得积分20
4秒前
甜蜜鹭洋完成签到 ,获得积分10
4秒前
xuxuxuuxuxux完成签到,获得积分10
4秒前
5秒前
月光族完成签到,获得积分10
5秒前
树下发布了新的文献求助10
5秒前
滴滴完成签到,获得积分20
7秒前
8秒前
七安发布了新的文献求助30
8秒前
LeePsy完成签到,获得积分10
8秒前
9秒前
深情安青应助hbutsj采纳,获得10
9秒前
小璐璐呀完成签到,获得积分10
10秒前
明亮安双完成签到,获得积分20
11秒前
Lemon完成签到,获得积分10
11秒前
sci一区作者完成签到,获得积分20
12秒前
包容柜子发布了新的文献求助10
12秒前
hhllhh发布了新的文献求助10
13秒前
河丫应助阳洋洋采纳,获得10
13秒前
13秒前
落霞与孤鹜齐飞完成签到,获得积分10
14秒前
14秒前
14秒前
hbuhfl完成签到,获得积分10
15秒前
小瑜完成签到,获得积分10
16秒前
小蘑菇应助Lemon采纳,获得10
16秒前
betty2009完成签到,获得积分10
16秒前
星星完成签到,获得积分10
16秒前
乐观如松关注了科研通微信公众号
16秒前
17秒前
Leo发布了新的文献求助20
18秒前
18秒前
幸运星完成签到,获得积分10
18秒前
包容柜子完成签到,获得积分10
19秒前
马某发布了新的文献求助10
19秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038426
求助须知:如何正确求助?哪些是违规求助? 3576119
关于积分的说明 11374556
捐赠科研通 3305834
什么是DOI,文献DOI怎么找? 1819339
邀请新用户注册赠送积分活动 892678
科研通“疑难数据库(出版商)”最低求助积分说明 815029